Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-26-000150
Filing Date
2026-07-31
Accepted
2026-07-31 16:17:41
Documents
89
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20260630.htm   iXBRL 10-Q 1474088
2 EX-3.1 exhibit31arby-laws.htm EX-3.1 208457
3 EX-31.1 exhibit31163026.htm EX-31.1 9109
4 EX-31.2 exhibit31263026.htm EX-31.2 9049
5 EX-32.1 exhibit32163026.htm EX-32.1 8266
11 mrna-20260630_g1.jpg GRAPHIC 63925
12 mrna-20260630_g2.jpg GRAPHIC 268063
  Complete submission text file 0001682852-26-000150.txt   10016779

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20260630.xsd EX-101.SCH 58933
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20260630_cal.xml EX-101.CAL 114179
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20260630_def.xml EX-101.DEF 234282
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20260630_lab.xml EX-101.LAB 683941
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20260630_pre.xml EX-101.PRE 476876
93 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20260630_htm.xml XML 1582581
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 261228764
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)